Transgenic Schizochytrium as a Promising Oral Vaccine Carrier: Potential Application in the Aquaculture Industry

<i>Schizochytrium limacinum</i> SR21, a kind of eukaryotic heterotrophic organism rich in unsaturated fatty acids, is an emerging microbial alternative to fish oil. The dietary inclusion of 15% SR21 was optimal for the growth performance of zebrafish. Previous studies demonstrated that fructose-1,6-bisphosphate aldolase (FBA) of <i>Edwardsiella tarda</i> is a valuable broad-spectrum antigen against various pathogens in aquaculture (e.g., <i>Aeromonas hydrophila</i>, <i>Vibro anguillarum</i>, <i>Vibro harveyi</i>, <i>Vibro alginolyticus</i>). We pioneered the development of stable <i>S. limacinum</i> SR21 transformants expressing the antigen protein FBA, exploring their potential as a novel oral vaccine for the aquaculture industry. The model animal zebrafish (<i>Danio rerio</i>) and ornamental fish koi carp (<i>Cyprinus carpio</i> koi) were harnessed to assess the immunoprotective effect, respectively. According to the quantitative expression analysis, zebrafish fed with recombinant <i>Schizochytrium</i> expressing FBA exhibited specific immune responses in the intestine. The expression levels of <i>MHC-I</i> and <i>MHC-II</i>, involved in cell-mediated adaptive immune responses, were significantly upregulated on the 14th and 28th days post-immunization. Additionally, the expression of highly specialized antibody genes <i>IgZ1</i> and <i>IgZ2</i> in mucosal immunity were significantly triggered on the 14th day post-immunization. Feeding koi carp with recombinant <i>S. limacinum</i> SR21-FBA increased the production of myeloperoxidase and FBA-specific antibodies in the sera. Furthermore, the sera of koi fed with recombinant <i>S. limacinum</i> SR21-FBA exhibited significant bactericidal activities against pathogen <i>E. tarda</i>. Thus, <i>S. limacinum</i> SR21 is a natural and highly promising oral vaccine carrier that not only provides essential nutrients as a functional feed ingredient but also offers specific immune protection to aquatic animals. This dual application is vital for promoting the sustainable development of the aquaculture industry.

Authors

Institutions

Publication Details

Journal
Marine Drugs
Published
2024-12-12
DOI
https://doi.org/10.3390/md22120555
Citations
2
Primary Topic
Aquaculture disease management and microbiota
Type
article
Field-Weighted Citation Impact
0.48

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transgenic Schizochytrium as a Promising Oral Vaccine Carrier: Potential Application in the Aquaculture Industry

Jianhua Fan, Haizhen Wu, Lei Deng, Yuan Gao et al.
2 citations
Marine Drugs
Aquaculture disease management and microbiota
0.48
article

Transgenic Schizochytrium as a Promising Oral Vaccine Carrier: Potential Application in the Aquaculture Industry

Jianhua Fan, Haizhen Wu, Lei Deng, Yuan Gao, Ke Ma, Yuanjie Wu
article en
2 citations

Abstract

<i>Schizochytrium limacinum</i> SR21, a kind of eukaryotic heterotrophic organism rich in unsaturated fatty acids, is an emerging microbial alternative to fish oil. The dietary inclusion of 15% SR21 was optimal for the growth performance of zebrafish. Previous studies demonstrated that fructose-1,6-bisphosphate aldolase (FBA) of <i>Edwardsiella tarda</i> is a valuable broad-spectrum antigen against various pathogens in aquaculture (e.g., <i>Aeromonas hydrophila</i>, <i>Vibro anguillarum</i>, <i>Vibro harveyi</i>, <i>Vibro alginolyticus</i>). We pioneered the development of stable <i>S. limacinum</i> SR21 transformants expressing the antigen protein FBA, exploring their potential as a novel oral vaccine for the aquaculture industry. The model animal zebrafish (<i>Danio rerio</i>) and ornamental fish koi carp (<i>Cyprinus carpio</i> koi) were harnessed to assess the immunoprotective effect, respectively. According to the quantitative expression analysis, zebrafish fed with recombinant <i>Schizochytrium</i> expressing FBA exhibited specific immune responses in the intestine. The expression levels of <i>MHC-I</i> and <i>MHC-II</i>, involved in cell-mediated adaptive immune responses, were significantly upregulated on the 14th and 28th days post-immunization. Additionally, the expression of highly specialized antibody genes <i>IgZ1</i> and <i>IgZ2</i> in mucosal immunity were significantly triggered on the 14th day post-immunization. Feeding koi carp with recombinant <i>S. limacinum</i> SR21-FBA increased the production of myeloperoxidase and FBA-specific antibodies in the sera. Furthermore, the sera of koi fed with recombinant <i>S. limacinum</i> SR21-FBA exhibited significant bactericidal activities against pathogen <i>E. tarda</i>. Thus, <i>S. limacinum</i> SR21 is a natural and highly promising oral vaccine carrier that not only provides essential nutrients as a functional feed ingredient but also offers specific immune protection to aquatic animals. This dual application is vital for promoting the sustainable development of the aquaculture industry.

Marine DrugsVol. 22(12)
East China University of Science and Technology (CN)
National Natural Science Foundation of China
Responsible consumption and production
Openalex Percentile: Top 33%
Aquaculture disease management and microbiota
0.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.